108 related articles for article (PubMed ID: 10525446)
1. Interleukin-1 and interleukin-1 fragments as vaccine adjuvants.
Boraschi D; Tagliabue A
Methods; 1999 Sep; 19(1):108-13. PubMed ID: 10525446
[TBL] [Abstract][Full Text] [Related]
2. Defining agonist peptides of human interleukin-1 beta.
Tagliabue A; Antoni G; Boraschi D
Lymphokine Res; 1989; 8(3):311-5. PubMed ID: 2789323
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of immune responses to the hepatitis B virus core protein through DNA vaccines with a DNA fragment encoding human IL-1beta 163-171 peptide.
Shao HJ; Chen L; Shen MS; Yu GF
Acta Virol; 2003; 47(4):217-21. PubMed ID: 15068376
[TBL] [Abstract][Full Text] [Related]
4. Defining the structural requirements of a biologically active domain of human IL-1 beta.
Boraschi D; Antoni G; Perin F; Villa L; Nencioni L; Ghiara P; Presentini R; Tagliabue A
Eur Cytokine Netw; 1990; 1(1):21-6. PubMed ID: 2102359
[TBL] [Abstract][Full Text] [Related]
5. In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta.
Nencioni L; Villa L; Tagliabue A; Antoni G; Presentini R; Perin F; Silvestri S; Boraschi D
J Immunol; 1987 Aug; 139(3):800-4. PubMed ID: 2955051
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant activity of the 163-171 peptide of human IL-1 beta administered through different routes.
Nencioni L; Villa L; Tagliabue A; Boraschi D
Lymphokine Res; 1987; 6(4):335-9. PubMed ID: 3501509
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody to the IL-1 beta peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1 beta in vivo.
Boraschi D; Volpini G; Villa L; Nencioni L; Scapigliati G; Nucci D; Antoni G; Matteucci G; Cioli F; Tagliabue A
J Immunol; 1989 Jul; 143(1):131-4. PubMed ID: 2786529
[TBL] [Abstract][Full Text] [Related]
8. Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis.
Lobell A; Weissert R; Eltayeb S; Svanholm C; Olsson T; Wigzell H
J Immunol; 1999 Nov; 163(9):4754-62. PubMed ID: 10528174
[TBL] [Abstract][Full Text] [Related]
9. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
Spohn G; Keller I; Beck M; Grest P; Jennings GT; Bachmann MF
Eur J Immunol; 2008 Mar; 38(3):877-87. PubMed ID: 18253928
[TBL] [Abstract][Full Text] [Related]
10. The immunostimulatory effect of IL-1beta in vivo is blocked by antisense peptides complementary to the loop sequence 163-171.
Boraschi D; Tagliabue A; Miller AD
FEBS Lett; 2009 Feb; 583(4):792-6. PubMed ID: 19185574
[TBL] [Abstract][Full Text] [Related]
11. Radioprotection by N-palmitoylated nonapeptide of human interleukin-1beta.
Singh VK; Srinivasan V; Seed TM; Jackson WE; Miner VE; Sree Kumar K
Peptides; 2005 Mar; 26(3):413-8. PubMed ID: 15652647
[TBL] [Abstract][Full Text] [Related]
12. Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains.
Ferrone CR; Perales MA; Goldberg SM; Somberg CJ; Hirschhorn-Cymerman D; Gregor PD; Turk MJ; Ramirez-Montagut T; Gold JS; Houghton AN; Wolchok JD
Clin Cancer Res; 2006 Sep; 12(18):5511-9. PubMed ID: 17000687
[TBL] [Abstract][Full Text] [Related]
13. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
Wozniak TM; Ryan AA; Triccas JA; Britton WJ
Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
[TBL] [Abstract][Full Text] [Related]
14. Radiation protection and restoration by the synthetic 163-171 nonapeptide of human interleukin 1 beta.
Frasca D; Baschieri S; Boraschi D; Tagliabue A; Doria G
Radiat Res; 1991 Oct; 128(1):43-7. PubMed ID: 1924727
[TBL] [Abstract][Full Text] [Related]
15. DNA fragment encoding human IL-1beta 163-171 peptide enhances the immune responses elicited in mice by DNA vaccine against foot-and-mouth disease.
Shao HJ; Chen L; Su YB
Vet Res Commun; 2005 Jan; 29(1):35-46. PubMed ID: 15727290
[TBL] [Abstract][Full Text] [Related]
16. Metabolic behavior and distribution of the synthetic nonapeptide fragment 163-171 of human IL-1 beta.
Pessina GP; Bocci V; Nicoletti C; Becherucci C; Presentini R; Parente L; Villa L; Tagliabue A; Boraschi D
Lymphokine Res; 1990; 9(3):371-9. PubMed ID: 2398742
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-18.
Dinarello CA
Methods; 1999 Sep; 19(1):121-32. PubMed ID: 10525448
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 1 as an adjuvant for active specific immunotherapy in a murine tumor model.
McCune CS; Marquis DM
Cancer Res; 1990 Feb; 50(4):1212-5. PubMed ID: 2297770
[TBL] [Abstract][Full Text] [Related]
19. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo.
Redlinger RE; Mailliard RB; Lotze MT; Barksdale EM
J Pediatr Surg; 2003 Mar; 38(3):301-7; discussion 301-7. PubMed ID: 12632339
[TBL] [Abstract][Full Text] [Related]
20. The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination.
Su B; Wang J; Wang X; Jin H; Zhao G; Ding Z; Kang Y; Wang B
Vaccine; 2008 Sep; 26(40):5111-22. PubMed ID: 18462845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
